- 1993
- Kirvela O
Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4.
primary studies published RCT
Details- 1993
- Lawrence R
Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
primary studies published RCT
Details- 1993
- Mortensen J
Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis.
primary studies published RCT
Details- 1993
- Nasr SZ
Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients.
primary studies published RCT
Details- 1993
- Portal B
Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
primary studies published RCT
Details- 1993
- Ramsey BW
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
primary studies published RCT
Details- 1993
- Ramsey BW
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
primary studies published RCT
Details- 1993
- Ranasinha C
The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis.
primary studies published RCT
Details- 1993
- Sanchez I
Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis.
primary studies published RCT
Details- 1993
- Sawyer EH